<!DOCTYPE html>
<html lang="en">
  <head>
            
   

<meta charset="UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<meta http-equiv="X-UA-Compatible" content="ie=edge" />

<link rel="shortcut icon" href="/wiki/assets/favicon.ico" type="image/x-icon" />

<title>08 Pituitary Pathology • Kang Rui Xiang's Notes</title>

<meta name="description" content="This is my wiki page" />

<meta property="og:title" content="08 Pituitary Pathology • Kang Rui Xiang's Notes" />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://kangruixiang.github.io/wiki//notes/08 Pituitary pathology/" />
<meta property="og:image" content="/assets/avatar.png" />
<meta property="og:description" content="This is my wiki page" />

<link rel="canonical" href="https://kangruixiang.github.io/wiki//notes/08 Pituitary pathology/" />

<link rel="stylesheet" href="/wiki/style.css" />

<style>
  @font-face {
    font-family: "Concourse";
    src: url("/wiki/assets/fonts/concourse_3_regular.woff2") format("woff2");
    font-style: normal;
  }
  @font-face {
    font-family: "Equity";
    src: url("/wiki/assets/fonts/equity_a_regular.woff2") format("woff2");
    font-style: normal;
  }
</style>

  </head>
  <body class="h-screen bg-ember scroll-smooth">
    <div
      class="fixed top-0 w-screen"
    >
    <div class="flex items-center justify-between max-w-4xl px-4 py-4 mx-auto md:px-10 bg-ember bg-opacity-90">
     <a href="/wiki/"> <svg xmlns="http://www.w3.org/2000/svg" class="w-8 h-8" viewBox="0 0 20 20" fill="currentColor">
  <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z" />
</svg></a>

      <nav class="flex space-x-2 font-semibold uppercase">
        <a href="/wiki/" class="p-4 rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Home</a
        >
        <a
          href="/wiki/notes/Step 1"
          class="p-4 font-semibold rounded hover:bg-zinc-800 hover:text-zinc-200"
          >Step 1</a
          >
      </nav>
    </div>
    </div>

    <div class="flex items-center justify-center flex-none max-w-4xl px-6 mx-auto mt-32 mb-32">
      <div  class="font-serif prose prose-lg prose-h1:text-xl prose-h2:text-lg md:prose-2xl md:prose-h1:text-4xl md:prose-h2:text-3xl prose-hr:border-zinc-900 hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200"><h1 id="08-pituitary-pathology" tabindex="-1">08 Pituitary pathology</h1>
<h2 id="pituitary-adenoma" tabindex="-1">Pituitary Adenoma</h2>
<!-- anterior pituitary adenoma are -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/bVXTqGu.jpg" alt="">..</p>
<!-- Nonfunctional anterior pituitary adenoma symptoms -->
<p>Symptoms</p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/lUOMTUT.jpg" alt="">.</p>
<h3 id="bitemporal-hemianopsia" tabindex="-1">Bitemporal hemianopsia</h3>
<!-- Bitemporal hemianopsia pathogenesis -->
<p>Pathogenesis:</p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/fkUWeJQ.jpg" alt="">.</p>
<ul>
<li>Pituitary is next to optic chiasm. Enlargement of pituitary can cause vision problems.</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/7DSnF27.jpg" alt=""></p>
<!-- anterior pituitary adenomas include -->
<p>Include:</p>
<ul>
<li>Prolactinoma: common</li>
<li>GH adenoma</li>
<li>ACTH adenoma: Cushings</li>
<li>TSH, LH, FSH: rare.</li>
</ul>
<h3 id="prolactinoma" tabindex="-1">Prolactinoma</h3>
<!-- Prolactinoma is, symptoms -->
<ul>
<li>Benign tumor of lactotroph. Inhibits GnRH, thus LH/FSH</li>
<li>Male: no breast lobular unit for milk</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/K4SoVlK.jpg" alt="">.</p>
<!-- Prolactinoma drug cause -->
<p>Dopamine antagonists such as the antipsychotic <strong>risperidone</strong> and <strong>haloperidol</strong>. Antiemetics, <strong>metoclopramide</strong>. All of these block D2 receptors..</p>
<!-- Prolactinoma treatment -->
<p>Treatment</p>
<ul>
<li>Dopamine agonists: <strong>bromocriptine or cabergoline</strong> to shrink tumor</li>
<li>Surgery.</li>
</ul>
<!-- bromocriptine, carbergoline are -->
<p>Dopamine agonists drugs.</p>
<h3 id="gh-excess" tabindex="-1">GH Excess</h3>
<!-- GH excess causes -->
<p>Causes are usually due to tumor. Presentation can be different depending on where the tumor is. If the tumor secretes GHRH and is in the <strong>hypothalamus</strong> or <strong>the sytem</strong>, there would be a high GHRH level. If the tumor is in the <strong>anterior pituitary</strong>, there would be a <strong>low GHRH and high somatostatin</strong> level.</p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/UxD3qsg.jpg" alt=""></p>
<p>.</p>
<!-- GH excess symptoms -->
<p>Symptoms</p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/XgWcqMs.jpg" alt=""></p>
<p>.</p>
<!-- GH Excess diagnosis -->
<p>Diagnosis</p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/y9E7Frh.jpg" alt=""></p>
<p>.</p>
<!-- GH Excess Treatment -->
<p>Treatment</p>
<ul>
<li><strong>pegvisomant</strong>: a GH receptor antagonist that effectively blocks IGF-1 production</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/GehNtNq.jpg" alt="">..</p>
<h3 id="acromegaly" tabindex="-1">Acromegaly</h3>
<!-- Acromegaly symptoms -->
<ul>
<li>Insidious onset, 12 yrs average: difficult to diagnose</li>
<li>Enlarged features
<ul>
<li>jaw, corse faces (enlarged nose, frontal bones)</li>
<li>tongue</li>
<li>hands and feet (rings no longer fit)</li>
<li>larynx (voice deepens)</li>
</ul>
</li>
<li>Enlarged visceral organs
<ul>
<li><strong>Cardiac failure</strong></li>
</ul>
</li>
<li>Enlarged joints: joint pain</li>
<li><strong>Secondary diabetes</strong> from GH induced liver gluconeogenesis</li>
<li>Increased risk of <strong>colon cancer</strong></li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/3tv4c5u.jpg" alt=""></p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/hPjI2HB.jpg" alt=""></p>
<p>.</p>
<h1 id="hypopituitarism" tabindex="-1">Hypopituitarism</h1>
<!-- Hypopituitarism is -->
<p>Describes the <strong>insufficient secretion of pituitary hormones resulting from diseases of the hypothalamus or the pituitary</strong>. .</p>
<!-- Hypopituitarism causes -->
<p>The majority of cases are secondary to destructive processes directly involving the anterior pituitary.  This includes:</p>
<ul>
<li>Tumors, such as <strong>nonfunctional pituitary adenomas</strong> (adnomas not producing hormones) or <strong>craniopharyngiomas</strong>(exert pressure on adjacent pituitary cells)</li>
<li><strong>Pituitary surgery or radiation</strong></li>
<li><strong>Traumatic brain injury</strong> and <strong>subarachnoid hemorrhage</strong></li>
<li><strong>Pituitary apoplexy</strong> (sudden hemorrhage into the pituitary gland)</li>
<li><strong>Sheehan syndrome</strong> (postpartum necrosis of the anterior pituitary secondary to infarction precipitated by obstetric hemorrhage or shock)</li>
<li><strong>Empty sella syndrome</strong> (presence of an enlarged, empty sella turcica due to a condition that partially or totally destroys the pituitary gland; classically affects obese women with a history of multiple pregnancies).
<img src="https://photos.thisispiggy.com/file/wikiFiles/9A3yz68.jpg" alt="">..</li>
</ul>
<!-- Hypopituitarism symptoms -->
<p>The clinical manifestation of hypopituitarism depends on the <em>specific hormone(s) that are lacking</em>.  For example, a deficiency of melanocyte stimulating hormone (MSH) may manifest as <strong>hypopigmentation, due to MSH's stimulatory effects on melanocytes</strong>.</p>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/5Y6Bgge.jpg" alt=""></p>
<p>Aldosterone part of RAAS system, not adrenal system...</p>
<!-- Hypopituitarism treatment -->
<p>The treatment for hypopituitarism includes hormone replacement therapy, including:</p>
<ul>
<li><strong>Corticosteroid</strong></li>
<li><strong>T4 (thyroxine)</strong></li>
<li><strong>Sex steroids</strong></li>
<li><strong>Human growth hormone</strong></li>
<li><strong>Pulsatile GnRH</strong> (for patients that desire fertility)..</li>
</ul>
<h2 id="empty-sella-syndrome" tabindex="-1">Empty Sella Syndrome</h2>
<!-- Empty Sella Pathogenesis -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/xeZZoD3.jpg" alt=""></p>
<ul>
<li>Arachnid and dura matter around sella. Pia matter around pituitary</li>
<li>Herniation of arachnoid and CSF into sella compresses and destroys pituitary: hypopituitarism</li>
<li>Sella filled with CSF, which is clear on imaging..</li>
</ul>
<!-- Empty Sella Syndrome Demographics -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/Uck4pd4.jpg" alt="">.</p>
<h2 id="pituitary-apoplexy" tabindex="-1">Pituitary Apoplexy</h2>
<!-- Pituitary Apoplexy is, risk, symptoms -->
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/04dzGzp.jpg" alt=""></p>
<p>.</p>
<h2 id="sheehan's-syndrome" tabindex="-1">Sheehan's Syndrome</h2>
<!-- Sheehan's syndrome pathogenesis -->
<p>Pituitary gland enlarged in preglancy as result of increased prolactin. However, the blood supply is not increased. In postpartum hemorrhage, pituitary is at risk of infarct from hypotension. ..</p>
<!-- Sheehan's syndrome symptoms -->
<p>Can present as shock after delivery from low cortisol levels if severe. If not severe, present as failure to lactate from loss of prolactin
<img src="https://photos.thisispiggy.com/file/wikiFiles/mYQoYjT.jpg" alt=""></p>
<p>Other symptoms:</p>
<ul>
<li>Absent menstruation from low FSH/LH</li>
<li><strong>Loss of pubic and axillary hair</strong> from low FSH/LH</li>
<li>Cold intolerance from low TSH</li>
<li>Fatigue from low GH</li>
<li>Anorexia</li>
</ul>
<p>.</p>
<h1 id="posterior-pituitary-pathology" tabindex="-1">Posterior Pituitary Pathology</h1>
<h2 id="di" tabindex="-1">DI</h2>
<!-- Diabetes insipidus 2 types -->
<p>Is due to:</p>
<ul>
<li>Central DI:  a <strong>lack of antidiuretic hormone</strong> (ADH)</li>
<li>Nephrogenic DI:  a **lack of ADH functionality **in the collecting tubules..</li>
</ul>
<!-- Diabetes Insipidus -->
<p>Is characterized by:</p>
<ul>
<li><strong>Dilute urine</strong> (even after water restriction)</li>
<li><strong>Intense thirst</strong></li>
<li><strong>Polyuria</strong>.</li>
</ul>
<!-- DI labs -->
<p>Labs:</p>
<ul>
<li>hypernatremia</li>
<li><strong>Urine specific gravity &lt; 1.006</strong></li>
<li><strong>Serum osmolarity &gt; 290 mOsm/L</strong>..</li>
</ul>
<!-- DI diagnosis -->
<p>A water restriction test is used to diagnose central and nephrogenc DI:</p>
<ol>
<li>Water intake is restricted for 2-3 hours, and urine volume, urine osmolality, plasma Na+ concentration, and plasma osmolality are measured hourly.</li>
<li>In healthy individuals, water deprivation leads to a urine osmolality 2-4 times greater than plasma osmolality.</li>
<li>In patients with central or nephrogenic DI, <strong>urine osmolality will be less than 300 mOsm/kg after water deprivation</strong>..</li>
</ol>
<!-- Differentiate between central and nephrogenic DI -->
<ul>
<li>Central: low ADH</li>
<li>Nephrogenic: high ADH</li>
</ul>
<p>DDAVP (desmopressin, an ADH analog) is administered to differentiate between central and nephrogenic DI:</p>
<ul>
<li>In central DI, DDAVP administration will result in a 50% or greater increase in urine osmolality.</li>
<li><strong>In nephrogenic DI, DDAVP administration will lead to no change in urine osmolality</strong>..</li>
</ul>
<h2 id="central-diabetes-insipidus" tabindex="-1">Central Diabetes Insipidus</h2>
<!-- Central Diabetes Insipidus cause -->
<ul>
<li>radiation, surgery, trauma</li>
</ul>
<p><img src="https://photos.thisispiggy.com/file/wikiFiles/ZPWwYkA.jpg" alt=""></p>
<p>.</p>
<!-- Central DI treatment -->
<p>Treatment: Desmopressin.</p>
<h2 id="nephrogenic-diabetes" tabindex="-1">Nephrogenic Diabetes</h2>
<!-- Nephrogenic DI causes -->
<p>Is due to the inability of the kidney to respond to ADH.  This may be due to an <strong>inherited mutation in the V2 receptor</strong> or secondary to:</p>
<ul>
<li><strong>Lithium</strong> (drug-induced nephrogenic DI)</li>
<li><strong>Demeclocycline</strong> (reduces responsiveness of kidney tubules to ADH) (treats SIADH)</li>
<li><strong>Hypercalcemia</strong> (causes natriuresis and water loss)</li>
<li><strong>Hypokalemia</strong> (decreases responsiveness of kidney tubules to ADH)</li>
<li><strong>Sickle cell disease</strong> (impairs renal response to ADH)..</li>
</ul>
<!-- Nephrogenic DI treatment -->
<p>Treatment involves:</p>
<ul>
<li><strong>Adequate hydration</strong></li>
<li><strong>Hydrochlorothiazide</strong> (see below)</li>
<li><strong>Indomethacin</strong></li>
<li><strong>Amiloride</strong>.</li>
</ul>
<p><em>Why treat a water-wasting disease with a thiazide diuretic?</em> Thiazides increase renal Na+ excretion, which leads to extracellular fluid volume contraction.  This decreased volume will decrease GFR, and increase proximal tubular reabsorption of water and Na+.  Therefore, ultimately less water and Na+ are lost as urine.</p>
<h2 id="siadh" tabindex="-1">SIADH</h2>
<!-- Syndrome of Inappropriate ADH cause -->
<p>Occurs when too much ADH is secreted by the posterior pituitary.  Common CNS causes of SIADH include:</p>
<ul>
<li>Brain infections (encephalitis)</li>
<li>Tumors of the pituitary, or tumors that impinge on the pituitary</li>
<li>Head trauma</li>
<li>Psychiatric illness</li>
</ul>
<p>Non-CNS causes of SIADH include:</p>
<ul>
<li>Medications (chlorpropamide, carbamazepine, cyclophosphamide and SSRIs)</li>
<li>Ectopic production by lung tumors (<strong>especially small cell carcinoma</strong>)</li>
<li>Pulmonary infection (viral, bacterial or tuberculous pneumonia)..</li>
</ul>
<!-- SIADH symptoms -->
<p>Patients will generally present with euvolemic hyponatremia.  Total body water is increased, but near-normal blood volume is maintained due to the body's compensatory response (decreased thirst, suppressed aldosterone release).  Peripheral edema does not develop.</p>
<!-- SIADH treatment -->
<p>If asymptomatic, the treatment of SIADH is free water restriction.</p>
<p>Treatment of SIADH includes:</p>
<ul>
<li>Demeclocycline, an antibiotic (tetracycline) used to treat SIADH because it induces a state of nephrogenic diabetes insipidus by inhibiting the actions of ADH in the kidney. This allows for diuresis and less retention of water.</li>
<li>Vaptans (conivaptan, tolvaptan), which are vasopressin antagonists</li>
<li>Hypertonic (5%) saline should also be administered if severe CNS changes (e.g. seizures) are present.</li>
</ul>
<p>It is important that hyponatremia be corrected slowly.  A rapid correction of hyponatremia can lead to <strong>central pontine myelinolysis (aka osmotic demyelination syndrome)</strong>..</p>
<!-- Central pontine myleinolysis pathogenesis -->
<p>Damage to the myelin sheath of the pons leads to the patient becoming &quot;locked in&quot;, with intact cognitive function but total muscle paralysis, with the exception of eye blinking..</p>
<!-- SIADH urine vs serum osmolarity -->
<p>In SIADH, urine osmolarity is greater than serum osmolarity..</p>

      </div>
    </div>
    
     <div class="fixed hidden ml-8 right-[5%] 2xl:block top-48 border-l-2 border-zinc-600 px-2"> 
        <nav class="toc" >
        <ul><li><a href="#pituitary-adenoma">Pituitary Adenoma</a><ul><li><a href="#bitemporal-hemianopsia">Bitemporal hemianopsia</a></li><li><a href="#prolactinoma">Prolactinoma</a></li><li><a href="#gh-excess">GH Excess</a></li><li><a href="#acromegaly">Acromegaly</a></li></ul></li><li><a href="#empty-sella-syndrome">Empty Sella Syndrome</a></li><li><a href="#pituitary-apoplexy">Pituitary Apoplexy</a></li><li><a href="#sheehan's-syndrome">Sheehan's Syndrome</a></li><li><a href="#di">DI</a></li><li><a href="#central-diabetes-insipidus">Central Diabetes Insipidus</a></li><li><a href="#nephrogenic-diabetes">Nephrogenic Diabetes</a></li><li><a href="#siadh">SIADH</a></li></ul>
      </nav>
      </div>


    <div class="max-w-4xl p-2 mx-auto font-sans font-semibold uppercase bg-emberdark">Backlinks</div>
    <div class="mx-auto font-serif prose prose-lg hover:prose-a:bg-zinc-800 hover:prose-a:text-zinc-200">
      
      <!-- <hr /> -->



<ul>
  
  <li>
    <div class="">
      <a href="/wiki//notes/step 1 Endocrinology/" class="peer">Step 1 Endocrinology</a>
      <div
        role="none"
        class="absolute hidden px-8 py-4 overflow-hidden prose-sm prose border rounded-md shadow-md w-fit max-h-80 peer-hover:block bg-ember prose-headings:hidden prose-hr:hidden"
      >
        <h1 id="step-1-endocrinology" tabindex="-1">step 1 Endocrinology</h1>
<ul>
<li>related: <a href="/wiki/notes/Step%201/">Step 1</a></li>
</ul>
<hr>
<ul>
<li><a href="/wiki/notes/01%20Thyroid/">01 Thyroid</a></li>
<li><a href="/wiki/notes/02%20Thyroid%20Disorders/">02 Thyroid Disorders</a></li>
<li><a href="/wiki/notes/03%20Adrenal%20Gland/">03 Adrenal Gland</a></li>
<li><a href="/wiki/notes/04%20Adrenal%20Disorders/">04 Adrenal Disorders</a></li>
<li><a href="/wiki/notes/05%20CAH/">05 CAH</a></li>
<li><a href="/wiki/notes/06%20Pituitary%20Anatomy/">06 Pituitary Anatomy</a></li>
<li><a href="/wiki/notes/07%20Pituitary%20Secretions/">07 Pituitary Secretions</a></li>
<li><a href="/wiki/notes/08%20Pituitary%20pathology/">08 Pituitary pathology</a></li>
<li><a href="/wiki/notes/10%20Endocrine%20Pancreas/">10 Endocrine Pancreas</a></li>
<li><a href="/wiki/notes/11%20Diabetes/">11 Diabetes</a></li>
<li><a href="/wiki/notes/12%20Diabetes%20Treatment/">12 Diabetes Treatment</a></li>
<li><a href="/wiki/notes/13%20Insulin/">13 Insulin</a></li>
<li><a href="/wiki/notes/14%20Parathyroid/">14 Parathyroid</a></li>
<li><a href="/wiki/notes/15%20MEN/">15 MEN</a></li>
</ul>

      </div>
    </div>
  </li>
  
</ul>


</div>

    <footer>
      <div class="max-w-6xl mx-auto mb-10 text-sm text-center mt-96">
        By Kang Rui Xiang
      </div>
      </div>
    </footer>
  </body>
</html>
